SwatiGoelMD

Myeloproliferative Disorder Hematology-Oncology

Associate Professor, Medicine, A Einstein Coll of Med of Yeshiva Univ

Dr. Goel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3411 Wayne Ave
Bronx, NY 10467
Phone+1 718-920-4137

Fax+1 718-882-8698

Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2007 - 2010
All India Institute of Medical SciencesClass of 2005

PubMed

Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis.
Josette Kamel, John Yan, Bradley Rockwell, Mendel Goldfinger, Eric J Feldman
Leukemia & Lymphoma. 2025-02-01
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database.
John Yan, M Bakri Hammami, John X Wei, Nishi Shah, Mendel Goldfinger
Annals of Hematology. 2024-09-01
3 citations
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang
Blood Advances. 2024-03-26

Abstracts/Posters

Direct Oral Anticoagulants for Prevention of Recurrent Thrombosis in Myeloproliferative Neoplasms
Swati Goel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Using Sociodemographic Data to Predict Survival in MyelofibrosisOctober 1st, 2024